KR20170054501A - 인지 기능을 개선시키기 위한 식물 추출물 - Google Patents

인지 기능을 개선시키기 위한 식물 추출물 Download PDF

Info

Publication number
KR20170054501A
KR20170054501A KR1020177010105A KR20177010105A KR20170054501A KR 20170054501 A KR20170054501 A KR 20170054501A KR 1020177010105 A KR1020177010105 A KR 1020177010105A KR 20177010105 A KR20177010105 A KR 20177010105A KR 20170054501 A KR20170054501 A KR 20170054501A
Authority
KR
South Korea
Prior art keywords
extract
plant
day
effective amount
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020177010105A
Other languages
English (en)
Korean (ko)
Inventor
미첼 체디아
켈리 헤어링거
브랜던 루이스
크리스틴 니만
슈린 펭
Original Assignee
케민 인더스트리즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 케민 인더스트리즈, 인코포레이티드 filed Critical 케민 인더스트리즈, 인코포레이티드
Priority to KR1020237043652A priority Critical patent/KR20240000637A/ko
Publication of KR20170054501A publication Critical patent/KR20170054501A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
KR1020177010105A 2014-09-15 2015-09-15 인지 기능을 개선시키기 위한 식물 추출물 Ceased KR20170054501A (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020237043652A KR20240000637A (ko) 2014-09-15 2015-09-15 인지 기능을 개선시키기 위한 식물 추출물

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462050563P 2014-09-15 2014-09-15
US62/050,563 2014-09-15
PCT/US2015/050230 WO2016044299A1 (en) 2014-09-15 2015-09-15 Plant extracts for improving cognitive function

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020237043652A Division KR20240000637A (ko) 2014-09-15 2015-09-15 인지 기능을 개선시키기 위한 식물 추출물

Publications (1)

Publication Number Publication Date
KR20170054501A true KR20170054501A (ko) 2017-05-17

Family

ID=55453722

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020177010105A Ceased KR20170054501A (ko) 2014-09-15 2015-09-15 인지 기능을 개선시키기 위한 식물 추출물
KR1020237043652A Pending KR20240000637A (ko) 2014-09-15 2015-09-15 인지 기능을 개선시키기 위한 식물 추출물

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020237043652A Pending KR20240000637A (ko) 2014-09-15 2015-09-15 인지 기능을 개선시키기 위한 식물 추출물

Country Status (8)

Country Link
US (2) US10857195B2 (https=)
EP (1) EP3194028A4 (https=)
JP (3) JP2017527591A (https=)
KR (2) KR20170054501A (https=)
AU (1) AU2015317990B2 (https=)
BR (1) BR112017005133A2 (https=)
CA (1) CA2961378A1 (https=)
WO (1) WO2016044299A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12213505B2 (en) 2021-07-05 2025-02-04 Healthy Ingredient Solutions, LLC Composition for promoting restful sleep and methods of making and using the same
CN116474049A (zh) * 2023-03-17 2023-07-25 深圳福图仁泰生物科技有限公司 一种兼具抗抑郁和促睡眠功效的植物天然水溶性复合物及其制备方法和应用
GB202402670D0 (en) * 2024-02-26 2024-04-10 Givaudan Sa Composition

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752476A (en) * 1986-02-18 1988-06-21 Copney Claudette V Sleep aiding herbal composition and method of utilizing same
US20060183776A9 (en) * 2000-03-03 2006-08-17 Eisai Co., Ltd. Liquid dosage formulations of donepezil
JP2002275061A (ja) * 2001-03-19 2002-09-25 Tsumura & Co 抗うつ・抗不安剤
JP3947149B2 (ja) * 2002-10-28 2007-07-18 高砂香料工業株式会社 消臭剤組成物
CN1566300A (zh) * 2003-07-09 2005-01-19 新疆芳香植物科技开发股份有限公司 制造香囊、香枕的芳香组合物及其制备方法
JP2005053891A (ja) * 2003-07-18 2005-03-03 Seresu Corporation:Kk リパーゼ阻害剤
US20050031761A1 (en) * 2003-08-05 2005-02-10 Donald Brucker Methods of producing a functionalized coffee
JP2006199666A (ja) * 2005-01-24 2006-08-03 Nagase & Co Ltd 健忘症の予防・治療剤
EP1930019A1 (en) * 2006-11-24 2008-06-11 DSMIP Assets B.V. Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses
CA2676353A1 (en) * 2007-01-24 2008-07-31 University Of Guelph Production of rosmarinic acid from spearmint and uses thereof
WO2008122099A1 (en) * 2007-04-05 2008-10-16 Iomedix Development International Srl Composition for promoting sleep and relaxation comprising lemon balm
EP2060192B9 (en) * 2007-10-17 2016-05-04 Rudolf Wild GmbH & Co. KG Composition comprising lemon balm extracts
PT2252309E (pt) * 2008-02-25 2012-12-10 Nestec Sa Composições nutricionais para a promoção do crescimento ósseo e manutenção da saúde óssea compreendendo extractos de, por exemplo, alecrim ou cominhos
JP2010106001A (ja) 2008-10-31 2010-05-13 Theravalues Corp Ｐｐａｒ活性化剤
JP2012518618A (ja) * 2009-02-20 2012-08-16 ディーエスエム アイピー アセッツ ビー．ブイ． 機敏さのためのオレガノ抽出物
CN102958529B (zh) * 2009-12-21 2015-12-09 马来西亚热带生物有限公司 有益地用作认知增强剂的肾茶提取物
US9545075B2 (en) * 2011-02-08 2017-01-17 Kemin Industries, Inc. Spearmint plant denominated KI-MsEM0110
US9545076B2 (en) * 2011-02-08 2017-01-17 Kemin Industries, Inc. Spearmint plant denominated KI-MsEM0042
JP5668258B2 (ja) * 2011-10-21 2015-02-12 ザ マッキス カンパニー インコーポレイテッド エゴマの葉マッコリ及びその製造方法
US20140044813A1 (en) * 2012-08-09 2014-02-13 Kemin Industries, Inc. Plant Extracts for Improving Cognitive Health and Function
US20140302170A1 (en) * 2013-04-08 2014-10-09 Scientific Nutrition Products, Inc. Compositions and methods for promoting sleep
AU2015210849B2 (en) * 2014-01-30 2018-11-22 Kemin Industries, Inc. Plant extracts for improving cognitive function

Also Published As

Publication number Publication date
BR112017005133A2 (en) 2018-01-23
CA2961378A1 (en) 2016-03-24
US20160074459A1 (en) 2016-03-17
US20160166629A1 (en) 2016-06-16
JP2022084873A (ja) 2022-06-07
EP3194028A4 (en) 2018-10-10
US10857195B2 (en) 2020-12-08
JP2017527591A (ja) 2017-09-21
AU2015317990A1 (en) 2017-04-06
AU2015317990B2 (en) 2020-04-30
KR20240000637A (ko) 2024-01-02
WO2016044299A1 (en) 2016-03-24
JP7818640B2 (ja) 2026-02-20
JP2024075715A (ja) 2024-06-04
EP3194028A1 (en) 2017-07-26

Similar Documents

Publication Publication Date Title
JP7360267B2 (ja) 認知機能を向上させるための植物抽出物
Wang et al. How does the tea L-theanine buffer stress and anxiety
JP7818640B2 (ja) 睡眠を改善するための植物抽出物
Khayat et al. Curcumin attenuates severity of premenstrual syndrome symptoms: A randomized, double-blind, placebo-controlled trial
Russo et al. Handbook of psychotropic herbs: A scientific analysis of herbal remedies for psychiatric conditions
Sarris et al. Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence
JP2021525709A (ja) 自閉症スペクトラム障害の治療のためのカンナビスベースの組成物
Wattanathorn et al. Positive modulation effect of 8‐week consumption of Kaempferia parviflora on health‐related physical fitness and oxidative status in healthy elderly volunteers
Jansson Alzheimer disease is substantially preventable in the United States–review of risk factors, therapy, and the prospects for an expert software system
CA3056731A1 (en) Compositions comprising essential oils for topical use
Bongartz et al. Sleep Promoting Effects of IQP‐AO‐101: A Double‐Blind, Randomized, Placebo‐Controlled Exploratory Trial
Recart et al. Therapeutic approaches employing natural compounds and derivatives for treating bipolar disorder: emphasis on experimental models of the manic phase
Morgan et al. Outcomes of self-help efforts in anxiety disorders
Tarfarosh et al. Search for a perfect Nootropic supplement combination-Can we increase human intelligence by nutritional supplements
Gadgil et al. Comparative Efficacy of Ekapākī (1x) and Daśapākī (10x) Brāhmī Ghr̥ta in Chronic Unpredictable Mild Stress Induced Behavioral Alterations in Rats
Ghaderi et al. The Effect Of Cinnamon Zeylanicum Essential Oil On Treatment Of Patients With Unipolar Nonpsychotic Major Depressive Disorder Treated With Fluoxetine
Bongartz et al. Research Article Sleep Promoting Effects of IQP-AO-101: A Double-Blind, Randomized, Placebo-Controlled Exploratory Trial
Sethi et al. Nutritional Deficiencies in Obsessive-Compulsive Disorder and Possible Treatment Interventions
Oken Non-prescription and non-pharmacological therapies for dementia
HABIB et al. Common Supplements for Anxiety.
Braun Kava Kava: Piper Methysticum

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20170413

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200709

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20211129

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20220621

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20211129

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20220621

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20220127

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20200709

Comment text: Amendment to Specification, etc.

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20221102

Patent event code: PE09021S01D

AMND Amendment
PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20230925

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20230428

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20221102

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20220921

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20220621

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20220127

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20211129

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20200709

X601 Decision of rejection after re-examination
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20231218